Advisor Group Holdings, Inc. Coh Bar, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.17 - $0.34 $1,445 - $2,890	-8,500 Reduced 57.39%	6,312 $1,000
Q1 2022 May 04, 2022	SELL	$0.25 - $0.43 $5,659 - $9,734	-22,638 Reduced 60.45%	14,812 $5,000
Q3 2021 Nov 05, 2021	BUY	$0.96 - $1.62 $5,760 - $9,720	6,000 Added 19.08%	37,450 $36,000
Q2 2021 Aug 02, 2021	BUY	$1.09 - $1.49 $2,725 - $3,725	2,500 Added 8.64%	31,450 $44,000
Q1 2021 May 13, 2021	BUY	$1.26 - $2.02 $5,985 - $9,595	4,750 Added 19.63%	28,950 $39,000
Q4 2020 Feb 10, 2021	BUY	$0.9 - $1.54 $21,780 - $37,268	24,200 New	24,200 $32,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.